Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.

MLA

Park SH, et al. “Comparison of Diffusion-Weighted MR Imaging and FDG PET/CT to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.” European Radiology, vol. 22, no. 1, Jan. 2012, pp. 18–25. EBSCOhost, https://doi.org/10.1007/s00330-011-2236-x.

APA

Park SH, Moon WK, Cho N, Chang JM, Im SA, Park IA, Kang KW, Han W, Noh DY, Park, S. H., Moon, W. K., Cho, N., Chang, J. M., Im, S.-A., Park, I. A., Kang, K. W., Han, W., & Noh, D.-Y. (2012). Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. European Radiology, 22(1), 18–25. https://doi.org/10.1007/s00330-011-2236-x

Chicago

Park SH, Moon WK, Cho N, Chang JM, Im SA, Park IA, Kang KW, et al. 2012. “Comparison of Diffusion-Weighted MR Imaging and FDG PET/CT to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.” European Radiology 22 (1): 18–25. doi:10.1007/s00330-011-2236-x.